Methods for assessing efficacy of renal neuromodulation and associated systems and devices
US12257433B2 · kind B2 · utility
0Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 2021 |
| Grant date | Mar 25, 2025 |
| Priority date | — |
| Expiry date | Dec 20, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided herein are methods, devices and compositions for assessing neuromodulation efficacy based on changes in the level of one or more biomarkers in plasma or urine collected from a human subject following a renal neuromodulation procedure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.